NURIX THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
NURIX THERAPEUTICS, INC. (NRIX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $94.76 million for the 12-month period ending 2022-11-30, per its 10-K filed 2025-01-28.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-01-28
- NURIX THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-08-31 was $94.76M.
- NURIX THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $94.76M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2022-11-30 | $94.76M 10-K · filed 2025-01-28 | |
| 2022-08-31 | $94.76M 10-Q · filed 2023-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |